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Summary: The cause-specific cumulative incidence function (CIF) quantifies the subject-specific disease risk with
competing risk outcome. With longitudinally collected biomarker data, it is of interest to dynamically update the
predicted CIF by incorporating the most recent biomarker as well as the cumulating longitudinal history. Motivated
by a longitudinal cohort study of chronic kidney disease, we propose a framework for dynamic prediction of end
stage renal disease using multivariate longitudinal biomarkers, accounting for the competing risk of death. The
proposed framework extends the landmark survival modeling to competing risks data, and implies that a distinct
sub-distribution hazard regression model is defined at each landmark time. The model parameters, prediction horizon,
longitudinal history and at-risk population are allowed to vary over the landmark time. When the measurement
times of biomarkers are irregularly spaced, the predictor variable may not be observed at the time of prediction.
Local polynomial is used to estimate the model parameters without explicitly imputing the predictor or modeling its
longitudinal trajectory. The proposed model leads to simple interpretation of the regression coefficients and closed-
form calculation of the predicted CIF. The estimation and prediction can be implemented through standard statistical
software with tractable computation. We conducted simulations to evaluate the performance of the estimation
procedure and predictive accuracy. The methodology is illustrated with data from the African American Study
of Kidney Disease and Hypertension.
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1. Introduction
Patients with chronic kidney disease (CKD) are at increased risk of end stage renal disease
(ESRD). Accurate prediction of the timing is of great importance in clinical research and
practice to facilitate preparation for renal replacement therapy and individualize clinical
decisions (Tangri et al., 2011). The typical ESRD risk equations are “static” prediction
models in the sense that they are developed from survival regression models that relate
the predictors at an earlier time point, such as baseline, to the time of ESRD (Echouffo-
Tcheugui and Kengne, 2012; Greene and Li, 2017). Longitudinal data of those biomarkers
between baseline and the terminal event are often available and potentially informative to
the disease progression, but they are not used in prediction model development.
In statistical literature, the prediction of the risk of clinical events using longitudinal
data is often referred to as dynamic prediction in the sense that the prediction can be updated
with accumulating longitiudinal data. Important fundamental work has been published in the
last decade (van Houwelingen and Putter, 2011; Van Houwelingen, 2007; van Houwelingen
and Putter, 2008; Zheng and Heagerty, 2005; Rizopoulos, 2011; Proust-Lima and Taylor,
2009). There are a number of challenges when this methodology is applied to the prediction
of ESRD among CKD population. First, CKD patients have increased chance of mortality
before reaching ESRD. Proper adjustment for competing risk is often needed in CKD
studies (Noordzij et al., 2013). Second, previous literature has identified a large number
of risk factors, including multiple biomarkers that are known to be causally associated with
ESRD (Tangri et al., 2011). Put in the longitudinal context, it requires that the dynamic
prediction model should accommodate multiple biomarkers with tractable computation.
Some biomarkers, such as the estimated GFR, have diverse nonlinear progression trajectories
(Li et al., 2012, 2013). This feature could add to the complexity of the statistical analysis
if modeling subject-specific longitudinal trajectories is needed. Third, it may take many
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years before a CKD patient reaches ESRD or death. The strength of association between
biomarkers and the disease outcome may vary over time, leading to time-varying effects.
Fourth, it is common that patients do not always follow a pre-specified clinical visits schedule.
Even if the visit times are non-informative in the sense that they are not related to the health
condition of the patients, the irregularly spaced and unsynchronized biomarker measurement
times pose a challenge to the development of dynamic prediction model, as elucidated below.
On the topic of dynamic prediction with competing risks data, Rue´ et al. (2017) and
Andrinopoulou et al. (2017) modeled the joint distribution of longitudinal data and compet-
ing risks with shared random effect models, and estimated the parameters with Markov chain
Monte Carlo. However, when a large number of random effects are needed to accommodate
multiple and possibly nonlinear longitudinal trajectories per subject, fitting the joint model is
computationally infeasible (Hickey et al., 2016). Cortese and Andersen (2010), Nicolaie et al.
(2012) and Nicolaie et al. (2013) studied the problem using an alternative, computationally
simpler approach called landmark modeling (van Houwelingen and Putter, 2011). Motivated
by the specific needs of CKD research, our proposed methodology in this paper is different
from the statistical literature above in some important aspects. First, the typical landmark
approach involves pre-specifying a number of landmark time points distributed over the
follow-up period, creating a landmark dataset at each landmark time point that consists
of at-risk subjects and their predictor variables and time-to-event, and fitting the model to
the stacked landmark datasets (van Houwelingen and Putter, 2011; Nicolaie et al., 2012).
The predictor variable is not always measured at the landmark times due to irregularly
spaced and unsynchronized measurement times. Imputing the unknown value by the last
or closest measurement is difficult to apply because that measurement could be years apart
and because the progression of CKD includes both chronic periods, when biomarkers change
slowly, and acute episodes, when biomarkers change more quickly. Our proposed method
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does not require pre-specification of the landmark times, which is important given that
there is currently no guideline in the literature on how to set the number and locations
of the landmark times. It can also accommodate the irregularly spaced observational times
without explicit imputation. Second, the proposed method estimates the time-varying model
parameters semiparametrically without imposing a parametric shape (Nicolaie et al., 2012;
van Houwelingen and Putter, 2011). Lastly, our approach is embedded within the framework
of Fine-Gray sub-distributional hazard model (Fine and Gray, 1999), while the previous
works were based on cause-specific hazard model (Nicolaie et al., 2012), pseudo-observations
(Nicolaie et al., 2013) and multi-state model (Cortese and Andersen, 2010). The Fine-Gray
model imposes a parsimonious relationship between predictors and the cumulative incidence
function (CIF) of ESRD without a separate model for death, which is difficult to establish
due to the heterogeneity in the causes of death.
2. The landmark dynamic prediction model for competing risks data
2.1 The notation and data structure
Let Ti and Ci be the time to the event of interest and time of censoring for subject i, and
i ∈ {1, . . . , K} be the K causes of the event. We observe the follow-up time T˜i = min(Ti, Ci),
the censoring indicator ∆i = 1(Ti 6 Ci), and event type ∆ii ∈ {0, . . . , K}. Without
loss of generality, we assume K = 2 throughout this paper. In the context of the data
application, event 1 denotes ESRD, the clinical event of interest, and event 2 denotes death,
the competing event. Let Y i = [Y i1,Y i2, . . . ,Y iq] denote the ni × q matrix of subject
i, with ni repeated measurements for each of the q covariates. This notation covers both
time-dependent (longitudinal) and time-independent (baseline) covariates. The repeated
measurements are made at time points ti = {ti1, ti2, . . . tini} (tij < T˜i), which are not
necessarily the same for all subjects. At any follow-up time u (u < T˜i), we denote by
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Hi(u) the observed covariate process within a history window [u − τ2, u], where Hi(u) =
{Y i(tij), tij | u − τ2 6 tij 6 u; j = 1, . . . , ni}. We observe independent and identically
distributed training data Dn = {T˜i,∆ii,Y i, ti, i = 1, . . . , n}, from which the dynamic
prediction model is to be developed. Our interest is to estimate, for a future individual
in the same population as the training data, indexed by subscript o, the probability of ESRD
in the next τ1 years (called prediction horizon) given survival up to time s and the covariate
information in the history window: pi(τ1|s,Ho(s)) = P (To ∈ (s, s+τ1], o = 1|T˜o > s,Ho(s)).
We assume that the distribution of ti is non-informative in the sense that it is independent of
Y i and Ti. We assume independent censoring in the sense that C is conditionally independent
of T and  given the baseline covariates.
In the following, we describe the construction of landmark dataset. We use notation
T (s) = T − s to denote the residual lifetime when a generic subject is at risk at time s.
For subject i in the development dataset, we define Tij = Ti − tij and Cij = Ci − tij as
the subject-specific residual times to event and censoring, starting from tij. For prediction
up to the horizon τ1, we can artificially censor the residual times at τ1, i.e., we observe
T˜ij = min(Tij, Cij, τ1) and the event indicator δ˜ij = 1
(
Tij 6 min(Cij, τ1)
) × i, where 1(·) is
the indicator function. The artificial censoring helps to reduce the chance of misspecifying
certain model assumptions (van Houwelingen and Putter, 2011). Throughout this paper, we
focus on modeling the relationship between T (s) and H(s) at any landmark time s. In the
model development dataset, T (s) and H(s) are observed at the longitudinal measurement
times tij (i = 1, 2, ..., n, j = 1, 2, ..., ni), leading to the observed outcome and predictor data
{T˜ij, δ˜ij,Hi(tij)}. Therefore, we also call tij as the landmark time as they are the starting
time of the residual lifetime outcome. When making a prediction, the new prediction is often
made when new measurements become available, i.e., at a new tij of that subject. From this
perspective, the prediction time is also called a landmark time.
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2.2 Sub-distribution hazard model with baseline covariates
We first briefly review the sub-distribution hazard (SDH) model for competing risks (Fine
and Gray, 1999) with baseline covariates X. For prediction, the quantity of interest is the
cumulative incidence function (CIF) given X: pi1(t
∗;X) = P (T 6 t∗,  = 1|X). Under Fine
and Gray’s formulation, this CIF is formulated as
P (T 6 t∗,  = 1|X) = 1− exp
(
−
∫ t∗
0
λ1(t|X)dt
)
(1)
with λ1(t|X) = λ10(t)exp(αTX), where λ10(t) can be any non-negative function of time
t > 0 and α is a real vector. Fine and Gray further developed an interpretation for the
λ1(t|X) function. They showed that it can be interpreted as a sub-distribution hazard, in
the sense that λ1(t;X) = lim∆t→0
1
∆t
P (t 6 T 6 t + ∆t,  = 1|{T > t} ∪ {T 6 t ∩  6=
1},X) = −dlog(1− pi1(t;X))
dt
. Such a definition can be viewed as the hazard function for
an improper random variable 1( = 1) × T + 1( 6= 1) ×∞. This interpretation also helps
the development of an estimation procedure that is analogous to that of the Cox model.
As far as prediction is of concern, characterizing the bilateral relationship between
time to event T ( = 1) and the covariate vector X is all that is needed. The sub-
distribution hazard value at a time t (t > 0) is not of direct relevance to this prediction.
The sub-distribution hazard function λ1(t|X) serves as the internal machinery that helps
the estimation of model (1). This is a key observation that motivates the working model in
the next subsection.
2.3 Landmark proportional sub-distribution hazard model
By extending model (1) to the context of dynamic prediction, we propose the following
landmark proportional SDH model at landmark time s:
P (T (s) 6 t∗,  = 1|H(s), T > s) = 1− exp
(
−
∫ t∗
0
λ1(t|H(s), s)dt
)
. (2)
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As the notation on the left hand side of (2) suggests, at any given landmark time s, this
model is specified for those subjects still at risk (T > s) at that time. If we treat the given s
as a new baseline, then this model is equivalent to a model (1) specified for the residual life
time T (s) among the at-risk subjects at time s, given the predictor variables defined from
H(s). Since there are in theory infinitely many landmark time s, model (2) is formulated
under the working assumption that these models hold simultaneously. For a specific landmark
dataset {T˜ij, δ˜ij,Hi(tij), tij; i = 1, . . . , n, j = 1, . . . , ni}, this model implies that the bilateral
relationship between each residual time to event (T˜ij, δ˜ij) and the corresponding “baseline”
predictor variables extracted from history Hi(tij) satisfies model (2) at the corresponding
landmark time s = tij. To fit this model, we define a working SDH function as:
λ1(t
∗|Hi(tij), tij) = λ10(t∗, tij)exp
(
βT (tij)Y˜ i(tij)
)
, t∗ ∈ (0, τ1], (3)
where λ10(t
∗, tij) is a bivariate smooth baseline SDH function, defined on the scale of the
residual lifetime t∗ ∈ (0, τ1] and landmark time tij. We use Y˜ i(tij) to denote the predictors
at visit time tij, which are functions of the observed history Hi(tij). The time-varying
coefficients β(.) are assumed to be smooth functions to allow the association to vary with the
landmark time. For the bilateral relationship between (T˜ij, δ˜ij) and Y˜ i(tij), the corresponding
value of the coefficient function is β(tij).
Our landmark dataset construction resembles that in the partly conditional model
(Zheng and Heagerty, 2005), which resets the follow-up time scale at each landmark time.
From this perspective, the basic idea of the proposed methodology is more closely related
to that model than the landmark model of Van Houwelingen (2007). However, besides
the accommodation of competing risk outcome, another difference between our approach
and Zheng and Heagerty (2005) is that the time-varying coefficients are functions of the
landmark time tij instead of the derived follow-up time t
∗. Therefore it differs from the
usual time-varying coefficient model in survival analysis that is commonly used to deal
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with non-proportional hazards (Cai and Sun, 2003). With the artificial censoring at τ1, the
covariate effect is more likely to be constant over t∗ ∈ (0, τ1) (but still vary with tij) and the
proportional sub-distribution assumption is more likely to hold. (Liu et al., 2016).
Model (3) is called a “working” sub-distribution hazard function because it is used
to facilitate the model fitting using the estimating equations developed by Fine and Gray
(1999). While it implies that a subject’s residual sub-distribution hazard at landmark time
s is λ1(t
∗ = 0|H(s), s), it does not imply that this subject’s sub-distribution hazard at time
s + t∗ (t∗ > 0) given the history H(s), is still given by (3). The hazard at time s + t∗
depends on H(s + t∗). In general, the hazard at time s + t∗ conditional on H(s) depends
on both the hazard at time s+ t∗ conditional on H(s+ t∗) and the conditional distribution
of the paths of longitudinal covariates Y˜ (u) (u ∈ (s, s + t∗)) given H(s). This is elucidated
by the concept of consistency (Jewell and Neilsen, 1993). Like other landmark (or partly
conditional) models, the proposed model has not been proven as a consistent prediction
model. However, this working model can still be a useful prediction tool as long as (2)
provides a good approximation to the bilateral relationship between (T˜ij, δ˜ij) and Y˜ i(tij).
3. Model estimation and dynamic prediction of the CIF
For estimation, we extend the kernel approach in Li et al. (2017) to the competing risk
context and formalize the idea of borrowing information from lagging covariates (Andersen
and Liestøl, 2003; Cao et al., 2015). Assume that β(.) has a continuous second derivative
in a neighborhood of s, by local linear approximation, β(tij) ≈ β(s) + β′(s)(tij − s) for
subject-specific time points tij around s. The landmark dataset Lm are clustered multivariate
time-to-event data with competing events, where the ni records from the same subject are
correlated. For clustered competing risk data (Zhou et al., 2012), we define the counting
process for event 1 as Nij(t
∗) = 1(tij 6 Ti 6 tij + t∗, δ˜ij = 1) and the at-risk process
Rij(t
∗) = 1 − Nij(t∗−) = 1(Ti > tij + t∗) + 1(tij 6 Ti 6 tij + t∗, δ˜ij 6= 1). Based on a
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local “working independence” partial likelihood function (Zhou et al., 2012), for any given
landmark point s, we can estimate the parameters β(s) using a kernel-weighted estimation
equation, by borrowing biomarker measurements from the neighboring time points, {tij ∈
(s− h, s+ h)}:
n∑
i=1
ni∑
j=1
Kh(tij − s)
∫ t∗
0
wij(t) ·
{
Z˜ij(1, tij − s)− Z¯(β(s), t)
}
· dNij(t). (4)
K(·) is a kernel function with bounded support on [−1, 1]. Kh(x) = h−1K(x/h) and h is the
bandwidth. Z˜ij(1, tij − s) = Y˜ (tij)⊗ (1, tij − s) with ⊗ denoting the Kronecker product. We
have the notations Z¯(β(s), t) =
Sˆ
(1)
(β(s), t)
Sˆ
(0)
(β(s), t)
, and
Sˆ
(r)
(β(s), t) =n−1
n∑
l=1
ni∑
m=1
Kh(tlm − s)wlm(t)Rlm(t)× Z˜ lm(1, tlm − s)⊗r
× exp
(
bT (s)Z˜ lm(1, tlm − s)
)
, (5)
where b(s) = {b0(s), b1(s)} = {β(s),β′(s)}, Z˜⊗0 = 1 and Z˜⊗0 = Z˜. The coefficient β(s)
is estimated at each landmark s using βˆ(s) = bˆ0(s). The variance of βˆ(s) can be estimated
by bootstrap, which involves randomly sampling n subjects from the original dataset with
replacement, estimating the point estimator from each randomly sampled bootstrap dataset,
and calculating the sample variance of the point estimators from all bootstrap datasets (Efron
and Tibshirani, 1993). The wij(·) in (4) denotes the inverse probability censoring weight for
competing events, modified from Fine and Gray (1999):
wij(t
∗) = 1
(
Cij > Tij ∧ t∗
) G(t∗|s)
G
(
Tij ∧ t∗|s
) ,
where G(t∗|s) = P (Cij > t∗|s) is the censoring distribution of the residual censoring time
at landmark s, and ∧ denotes the minimum of the two values. We use a kernel-weighted
Kaplan-Meier estimator for the residual censoring distribution, estimated from the residual
time to censoring around s:
Ĝ(t∗|s) =
∏
ζ∈Ω,ζ6t
{
1−
∑
lKh(tlm − s) · 1(C˜lm = ζ, δ˜lm = 0)∑
lKh(tlm − s) · 1(C˜lm > ζ)
}
.
Dynamic Prediction of Competing Risk Events 9
Once we obtain the estimates of β(s), the baseline cumulative SDH function at time s can
be estimated by plugging in βˆ(s):
Λˆ10(t
∗, s) =
1
n
n∑
i=1
ni∑
j=1
Kh(tij − s)
∫ t∗
0
1
Sˆ
(0)
(βˆ(s), t)
wˆij(t)dNij(t).
The conditional CIF for any future subject o can be estimated as
pˆi1(t
∗|s,Ho(s)) = Pˆ (s < To 6 s+ t∗, o = 1|T˜o > s,Ho(s))
= 1− exp
(
− Λˆ10(t∗, s)× exp
(
βˆ
T
(s)Y˜ o(s)
))
. (6)
4. Quantifying the dynamic predictive accuracy
In this section, we study two predictive accuracy measures, the time-dependent receiver
operating characteristic (ROC) curve, in particular the area under the ROC curve (AUC);
and the Brier score (BS). In the dynamic prediction framework, the time-dependent pre-
dictive accuracy measures are functions of two time scales, the landmark time s and the
prediction horizon τ1. The following procedure for estimating sensitivity, specificity, and BS
were modified from the non-parametric kernel-weighted approach of Wu and Li (2018) for
competing risk data.
4.1 The dynamic time-dependent ROC curve and AUC
At any landmark time s, we want to evaluate how well the risk score, i.e., the estimated CIF,
discriminates between subjects with the event of interest in the window (s, s+τ1] versus those
without. For any at-risk subject at time s who experiences the main event within the time
interval (s, s+τ1], that occurrence is defined as a case:D
+(s, τ1) = {i : s < Ti 6 s+τ1, i = 1}.
When a subject is event-free at s + τ1, that occurrence is defined as a control: D
−(s, τ1) =
{i : Ti > s + τ1}. An alternative definition for a control is to use the complementary set
D¯+(s, τ1) = {i : (s < Ti 6 s+τ1, i 6= 1)∪ (Ti > s+τ1)}, including subjects who experience a
competing event within the time interval (s, s+τ1] or remain event-free at s+τ1. To illustrate
the ideas, we present the estimators for the former in this subsection. A similar extension can
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be made for the latter. For simplicity, we use the notation U(τ1|s) to denote the individual
predicted CIF (i.e., the risk score). Given a threshold value c ∈ (0, 1) , the time-dependent
sensitivity and specificity functions are defined as Se(c, s, τ1) = P
(
U(τ1|s) > c|D+(s, τ1)
)
and Sp(c, s, τ1) = P
(
U(τ1|s) 6 c|D−(s, τ1)
)
. The estimators of sensitivity and specificity are
Ŝe(c, s, τ1) =
∑
i∈<s Wˆ
dyn
1i · 1(Ui(τ1|s) > c)∑
i∈<s Wˆ
dyn
1i
Ŝp(c, s, τ1) =
∑
i∈<s(1−
∑K
k=1 Wˆ
dyn
ki ) · 1(Ui(τ1|s) 6 c)∑
i∈<s(1−
∑K
k=1 Wˆ
dyn
ki )
,
where W dyn1i = P
(
Ti(s) ∈ (0, τ1], i = 1|T˜i(s), δi, Ui
)
= 1(δ˜ij = 0) · F1(τ1|Ui,s)−F1(T˜i(s)|Ui,s)S(T˜i(s)|Ui,s) +
1(δ˜ij = 1), Ti(s) = Ti− s, T˜i(s) = T˜i− s and Ui is short for Ui(τ1|s). <s is risk set within the
neighborhood of s which includes the most recent record at tij for each subject i {i : T˜i >
s, |tij − s| 6 |tij′ − s|,∀j ′ = 1, 2, . . . , ni, tij ∈ (s− h, s + h)}. F1(x|Ui, s) = P (Ti(s) 6 x, i =
1|Ui, s) and S(x|Ui, s) = P (Ti(s) > x|Ui, s).
For estimating the conditional probability weight W dyn1i , we treat the at-risk data set
at landmark s as the new baseline data set. The time-dependent ROC curve is a plot of
sensitivity Se(c, s, τ1) over 1-specificity 1 − Sp(c, s, τ1), i.e., for x ∈ [0, 1], RÔC(x, s, τ1) =
Ŝe(Ŝp
−1
(1− x, s, τ1), s, τ1). The AUC is estimated as ÂUC(s, τ1) =
∫ 1
0
R̂OC(x, s, τ1)dx.
4.2 The dynamic time-dependent Brier score
The time-dependent BS under the dynamic competing risk framework is defined asBS(τ1, s) =
E
(
1(s < T 6 s+ τ1,  = 1)−U(τ1|s)
∣∣T > s)2, where 1(·) is the indicator function. Applying
the weight W dyn1i , the BS can be estimated as
B̂S(τ1, s) =
1
ns
ns∑
i=1
(
Wˆ dyn1i × (1− U(τ1|s))2 + (1− Wˆ dyn1i )× (0− U(τ1|s))2
)
,
where ns is the number of subjects at risk at landmark time s.
The AUC and BS assess different aspects of the predictive model. AUC evaluates the
discrimination between a case and a control, and BS quantifies the deviance of the predicted
probability from the observed data. A model with perfect discrimination will have AUC = 1,
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while AUC close to 0.5 indicates poor discrimination that resembles a random guess. BS is
a prediction error metric, with smaller values indicating better prediction.
5. Simulation
The simulation in this section mainly evaluates the prediction accuracy of the proposed
model. A separate simulation, which evaluates the estimation of model parameters and
bandwidth selection under the assumptions of the working model, is presented in the Web
Appendix B. Similar to other studies evaluating the prediction accuracy of landmark models
(Maziarz et al., 2017), we simulated longitudinal and competing risks data from a joint frailty
model with shared random effects (Elashoff et al., 2008). Details of the data generation
process are described in the Web Appendix A. The data generating model included a
baseline covariate and three longitudinal biomarkers. We considered two scenarios: (S1) the
longitudinal biomarkers are non-informative for survival in the sense that their effects on
both time-to-event outcome are zero, and (S2) the longitudinal biomarkers are informative
in the sense that they have non-zero regression coefficients on both time-to-event outcomes.
The incremental contribution of the longitudinal biomarkers to the prediction accuracy is
expected to be zero under S1 and non-zero under S2.
Table 1 presents the predictive accuracy of the proposed model under both S1 and S2.
The full model (M1) includes both the longitudinal biomarkers and the baseline covariate;
the null model (M0) only includes the baseline covariate. Since the data were simulated
from a joint frailty model (Elashoff et al., 2008), the proposed landmark SDH model worked
under misspecification. However, regardless of whether the data generating model matches
the fitting model, the predictive performance can always be evaluated. We considered both
discrimination and calibration measures in Table 1. For discrimination, we reported the
true positive (TP) fraction and false positive (FP) fraction at a given threshold value, and
the AUC as a global discrimination summary. For calibration, we used the Brier score.
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The predictive accuracy measures were evaluated at three landmark times s = 3, 5, 7 with
prediction horizon τ1 = 1, 3. For each simulation, the proposed model was fit to a simulated
training data set and the predictive accuracy measures were calculated from another simu-
lated validation dataset from the same distribution. When all the longitudinal biomarkers
are non-informative, the predictive accuracy measures of the full model and the null model
are very similar. When the three longitudinal biomarkers are informative, including the
longitudinal biomarkers in the prediction model substantially improves both discrimination
and calibration.
[Table 1 about here.]
Under S2, the estimated regression parameters of the proposed SDH model are plotted
in Web Figure 1, which shows that the effects of the three longitudinal biomarkers are notably
different from zero and are in the right direction suggested by the data generating model. In
contrast, the estimated regression parameters of the proposed SDH model are close to zero
when data were generated under S1.
We conducted additional simulation to compare the predicted and true conditional
risks at individual level. The true conditional risk of an individual (indexed by subscript
o, at landmark time s, conditional on biomarker history H(s), and with prediction horizon
τ1) is defined as pi(τ1|s,Ho(s)) = P (To ∈ (s, s + τ1], o = 1|T˜o > s,Ho(s)). Since the true
conditional risk varies by subject, landmark time and history, and does not have a tractable
analytical expression, we calculated it empirically at 9 representative landmark time by
history combinations (Web Table 1) as follows. We simulated data using the procedure in
Web Appendix A but with one informative longitudinal biomarker Y2 (the effect of Y1, Y3,
and X on the time-to-event outcome were all set to zero). The true CIF for the event of
interest in the next τ1 = 3 years were obtained empirically as the proportion of subjects with
that event within (s, s+ τ1] give survival up to time s, among those with nearly identical Y2.
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For illustration, we chose three target Y2 values: m = 0, 2 and 4 in Web Table 1. Subjects
with marker values within ±0.05 of the target value were counted in the denominator of
the proportion calculation. To ensure that there were enough subjects in the denominator,
we simulated a very large dataset (n = 1, 000, 000) without censoring. We restricted to
the case of a single informative biomarker (Y2) because it is less feasible to match subjects
on multiple biomarkers. The conditional CIFs for hypothetical subjects with marker value
0, 2, 4 at landmark times 1, 3, 5 were estimated from 500 Monte Carlo repetitions. The average
estimated CIF (EST), empirical standard deviation (ESD), percent bias (% Bias) and mean
squared error (MSE) are presented in Web Table 1. Being a working model, the proposed
semi-parametric landmark SDH model worked under mis-specification in this simulation.
However, the result suggests that the estimated CIF has little bias and the MSE is low. It
may indicate that the proposed model was flexible enough to provide approximate the data
well at multiple landmark times, despite that the simulated data do not exactly satisfy the
working assumptions. Unlike the simulation results in Table 1, the results in Web Table 1
pertain to the quality of predictions at individual level.
The proposed landmark SDH model is a working model and it is not yet clear whether
there exists a joint distirbution of longitudinal and competing risk data such that the model
holds at all landmark times. This is a well known difficulty with landmark dynamic prediction
models in general (van Houwelingen and Putter, 2011; Li et al., 2017) and it is not specific to
our landmark model, though limited progress has been made in problems without competing
risks (Zheng and Heagerty, 2005; Zhu, Li and Huang, 2018, 2019). Due to this difficulty,
researchers often evaluate the numerical performance of the landmark models using data
simulated from the joint model with shared random effects (Maziarz et al., 2017; Huang
et al., 2016). This is also the simulation strategy that we chose. When the data generation
model and the analysis model do not match, the estimated model parameters are difficult
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to evaluate and interpret, but prediction accuracy can still be assessed. We have designed
scenarios S1 and S2 to demonstrate that incorporating informative longitudinal biomarkers
improves predictive accuracy. This qualitative conclusion is unlikely to be invalidated by
the magnitude of model misspecification. We designed three longitudinal biomarkers with
complicated trajectories to demonstrate that the proposed model works in situations where
joint modeling approaches may be difficult to apply.
6. Application to the AASK data
The AASK study included 1, 094 African Americans of age 18 to 70 years who were diagnosed
with hypertensive renal disease and had baseline eGFRs between 20 − 65mL/min/1.73m2
(Wright Jr et al., 2002). Subjects were followed every 6 months, with up to 12 years of longi-
tudinal data collected at each visit. By the end of the study, 318 (29%) individuals developed
ESRD, the event of research interest, and 176 (16%) died before ESRD. The median time to
ESRD was 4.3 years and the median time to death was 5.2 years. We chose clinically relevant
prediction horizons of τ1 = 1 or 3 years and illustrated the dynamic prediction at years 3, 5,
and 7. The key longitudinal biomarker is eGFR (estimated Glomerular Filteration Rate). Our
previous publication demonstrated that this biomarker have diverse and possibly nonlinear
individual progression patterns (Li et al., 2012). In addition, some CKD patients experienced
acute kidney injury (AKI) during the follow-up, which may cause substantial short term
variation in the eGFR (e.g., see Figure 2 of Li et al. (2017)). The number of repeated
measurements for eGFR ranged from 3 to 30, with over 50% of individuals providing 17 or
more measurements. In addition to the current value of eGFR at a clinical visit, we derived
the rate of change in eGFR (linear eGFR slope) during the history window of τ2 = 3 years,
because the eGFR slope is often used by clinicians to characterize the speed of progression
in CKD (Schluchter, Greene, and Beck, 2001). The estimation of eGFR slope followed the
approach in our recent paper (Li et al., 2017). Additional biomarkers included longitudinal
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measurements of serum albumin (Alb), urine protein to creatinine ratio (UP/Cr), serum
phosphorus (Phos) and urine potassium (Upot). These biomarkers were considered because
they have known biological association with disease progression and have been used in other
CKD risk equations (Tangri et al., 2011). Also included in the prediction model were age at
the time of prediction and an indicator of any hospitalization during the previous year.
For the competing events of ESRD and death, we fit landmark SDH models separately
using the same set of candidate predictors (Web Figure 2). The eGFR, its rate of change,
and log UP/Cr were significantly associated with time to ESRD but not with time to death.
In contrast, age, Alb and hospitalization are risk factors related to death. This indicates
that the progression to ESRD and death may be related to different pathological processes,
which justifies the proposal of modeling the competing events separately rather than as
a composite outcome. After removal of the non-significant covariates, the final model for
ESRD included eGFR, eGFR.slope, log UP/Cr and Phos, and the final model for death
included age, Alb, log-Upot and hospitalization (Web Figure 3). We conducted bandwidth
selection using 5-fold cross-validation. Predictive accuracy metrics were evaluated in the
cross-validation dataset, and they were robust to different bandwidths (up to 3 digits after
the decimal point). Therefore, we used the bandwidth of h = 1.5 in the final model, which
provided a relatively smooth curve for the log-SDH ratio curve.The surface plots of the CIF
for ESRD and death are illustrated in Figure 1.
[Figure 1 about here.]
Figure 2 presents the longitudinal profiles and individual dynamic predictions from
three AASK subjects: subject 1 was event-free by the end of the study, subject 2 experienced
ESRD after 7.5 years, and subject 3 died after 9.7 years. We demonstrated the biomarker
values with real-time predicted 3-year probabilities of ESRD and death. The risk prediction
was dynamically updated at each new clinical visit. Subject 1 demonstrated stable disease.
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Subject 2 demonstrated persistent decline in eGFR and notable increase in proteinuria (log-
UP/Cr), which led to drastic increase in the risk of ESRD after year 5. In contrast, the
risk of death for subject 2 increased moderately, which may be explained by the Alb level
and hospitalization around year 7. For subject 3, the relatively stable eGFR and log-Up/Cr
also stablized the subject’s susceptibility to ESRD, but the frequent hospitalization and
decreasing Alb level were associated with increased risk of death, possibly due to other
co-morbidity. We did not estimate the model after year 8 because the number of observed
clinical events was relatively small near the end of the follow-up.
[Figure 2 about here.]
Figure 3 presents the profiles of the same three patients but with their dynamic CIFs
(up to τ1 = 3 years) at landmark times s = 3, 5, 7 years. For subject 1, the predicted CIFs
for both ESRD and death were flat. In contrast, the predicted CIF of ESRD for subject 2
started to increase after year 5 and the increase became very prominent by year 7. This was
likely caused by a combination of deteriorated renal function (eGFR) and proteinuria (log-
UP/Cr). This patient reached ESRD shortly after year 7. The predicted CIF of ESRD for
subject 3 stayed flat, but the CIF of death increased at year 7, after frequent hospitalization.
This subject eventually died at year 9.6 without ESRD.
[Figure 3 about here.]
In Table 2, we summarized the predictive accuracy of the landmark SDH models for
prediction horizons τ1 = 1, 3 at three landmark years s = 3, 5, 7. The model for ESRD
achieved good discrimination with AUCs between 0.93-0.96. When we used the cutoff value
of 0.05, the sensitivity (TP) and specificity (1-FP) could be controlled within 0.80-0.90 range
under all scenarios. The prediction accuracy metrics were similar with different prediction
horizons. In contrast, the model for death discriminated no better than a random guess,
resulting in AUCs around 0.5; the prediction errors were also at least twice as large as those
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from predicting ESRD. More importantly, the AUCs from the proposed model improved
in comparison with previous studies where AUCs were around 0.8 and always less than
0.9 (Li et al., 2017; Maziarz et al., 2017). One possible explanation is that these previous
studies treat “time to ESRD or death” as a composite outcome. This introduces noise and
diminishes the predictive accuracy because all-cause death is difficult to predict with the
selected biomarkers, which are prognostically specific to renal disease. The ROC curves for
predicting ESRD were plotted in Web Figure 4.
[Table 2 about here.]
7. Discussion
For CKD patients, estimating the time to ESRD is crucial for the timely treatment man-
agement. Dynamic prediction is an attractive tool for this purpose, because it is adaptive
to the changing health condition and prognostic history of the patient. It enables real-
time monitoring of patient risk. In this paper, we develop novel methodology for dynamic
prediction of ESRD among the CKD patients, and we overcome a number of analytical
hurdles, including competing events of death, irregularly spaced clinical visit times, multiple
biomarkers with complicated longitudinal trajectories, time-varying at-risk population, and
time-varying covariate-outcome association. Our proposed methodology is flexible, because
the model parameters are estimated semi-parametrically. Hence, it can effectively mitigate
the risk of model misspecification. This feature is very important for dynamic prediction
models, because, as explained in Section 5, the landmark dynamic prediction model is a
working model and needs to provide adequate approximation to the data at all landmark
times. Another advantage of the proposed methodology is that it is computationally simple,
and it can be implemented through standard statistical software for competing risks analysis,
regardless of how many longitudinal biomarkers are included as predictors. In this paper, the
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estimation process was accomplished with the available R function coxph() after translating
the competing events into a counting process (Geskus, 2011). We believe that the simplicity
in computation makes the proposed methodology attractive for various practical situations,
including applications with large datasets, a large number of biomarkers with complicated
longitudinal trajectories, and other longitudinal prognostic information that cannot be easily
modeled at an individual-level (e.g., hospitalization episodes and medication history).
Our kernel-based estimation approach relies on the assumption that the clinical visit
times are non-informative. Future work is needed to study dynamic prediction when the
frequency of clinical visits is related to the health condition of the patients. The predictors
in our proposed model framework include pre-specified features extracted from the data
history. Automatic extraction of predictive features from the longitudinal history is another
topic that we will pursue in future research.
Supplementary Materials
Web Appendices, Web Figures, and R code are available with this paper at the Biometrics
website on Wiley Online Library.
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Figure 1. Estimated surface of the cumulative incidence function over the landmark time
and prediction horizon. This shows an examplary population with age = 55, eGFR = 45
ml/min/1.73m2, eGFR.slope = 0, UP/Cr = 0.3 g/g, albumin = 4 g/dL, and hospitalization
within the past year.
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Figure 2. Individual risk predictions for three selected subjects: subject 1 was cen-
sored (dotted vertical green line), subject 2 had ESRD (dotted vertical red line) and
subject 3 died (dotted vertical black line). Three biomarkers are plotted over time: “G”
is eGFR (ml/min/1.73m2), “R” is log-urine protein-to-creatinine ratio (g/g), and “A” is
albumin(g/dL). The connected red dots are predicted probabilities of ESRD within a horizon
of τ1 = 3 years. The gray vertical bars represent episodes of hospitalization, with the two
vertical borders being admission and discharge dates. The connected black dots are the
predicted probability of death within τ1 = 3 years. The y-axis to the left is the scale of
eGFR, and the y-axis to the right is the scale of predicted probabilities (0 to 1). The other
two biomarkers, log-UP/CR and albumin, are re-scaled to be displayed in the same plot
with eGFR but their respective scales are not shown. The dynamic predicted probabilities of
ESRD are calculated using the dynamic SDH model with four predictors: eGFR, eGFR slope
in the past three years, log-UP/CR and phosphorus. The dynamic predicted probabilities of
death are calculated using the dynamic SDH model with four predictors: current age, serum
albumin, any hospitalization within the past year, and log urine potassium.
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Web-based Supplementary Materials for
“Dynamic Prediction of Competing Risk Events using Landmark
Sub-distribution Hazard Model with Multiple Longitudinal
Biomarkers”
by Cai Wu, Liang Li, and Ruosha Li
Web Appendix A: Data Generation Procedure for Simulation
The simulation results are presented in main text of the paper. This section presents details of the
data generation procedure and parameter settings. The longitudinal processes are generated from
equation (1) below. We simulated a total of n subjects with independent and identically distributed
data for each simulation run.
Yi1(tij) = mi1(tij) + i1(tij) = bi01 + bi11 · tij + i1(tij)
Yi2(tij) = mi2(tij) + i2(tij) = bi02 + bi12 · t3ij + i2(tij) (1)
logit{P (Yi3(tij) = 1)} = mi3(tij) = bi03 + bi13 · tij ,
For both non-informative biomarker effect (S1) and informative biomarker effect (S2), the data
were simulated according to the joint frailty model of longitudinal biomarkers and the competing
risk event times (Elashoff et al, 2008). It includes the longitudinal sub-model and the following
survival sub-model (k = 1, 2):
λk(t) = λk0(t)exp{γkXi +
3∑
q=1
βkqmiq(t) + vkui}. (2)
The baseline hazard for the time-to-event outcome follows Weibull distribution with scale and
shape parameters of (0.02, 2.3) and (0.01, 2.4) for event 1 and event 2 respectively. The lon-
gitudinal sub-model includes three longitudinal biomarkers. The first one Yi1(.) is a continuous
biomarker with a linear mean trajectory mi1(.). The second biomarker Yi2(.) has a nonlinear
subject-specific mean trajectory. The third biomarker is binary with a logit-linear mean trajec-
tory. For the first two biomarkers, i1(.) and i2(.) are random noises with N(0, 0.5
2) distribu-
tion. Each biomarker’s longitudinal trajectory is characterized by two random effects, denoted by
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bip = (bi0p, bi1p)
T (p = 1, 2, 3). In the case of a linear trajectory, such as the first biomarker, they rep-
resent the subject-specific random intercept and slope. We let bi = (b
T
i1, b
T
i2, b
T
i3)
T ∼MVN(Ω,D),
where Ω = (2.8,−0.14, 2.1, 0.01,−1, 0.3) denote the population mean. The covariance matrix D
can be decomposed intoD = diag(σq)×R×diag(σq), where the diagonal matrix diag(σq) includes
elements σq = (σ01, σ11, σ02, σ12, σ03, σ13) = (0.9, 0.1, 0.9, 0.005, 0.9, 0.1) and correlation matrix R.
R =

1 0.26 −0.5 −0.3 −0.5 −0.3
1 −0.65 −0.3 −0.5 −0.3
1 0.35 0.5 0.3
1 0.5 0.3
1 0.3
1

.
In the survival sub-model, ui is the frailty term accounting for the correlation between two com-
peting events, and the parameter v1 is set to 1 to ensure identifiability. We let ui ∼ N(0, σ2u)
where σu = 0.5. For S1, {β1q} and {β2q} are all set to be zero. For S2, we set {β1q; q =
1, 2, 3} = (−1.2, 0.3, 1.5) and {β2q; q = 1, 2, 3} = (−0.2, 0.05, 0.6). For both S1 and S2, the
sub-model includes one baseline covariate Xi ∼ N(0.5, 0.52) with regression coefficient γ1 =
−1.5 and γ2 = −1. The censoring times are generated from a mixture of uniform distribution
η1Unif(0, 3) + η2Unif(3, 6) + η3Unif(6, 9) + η4Unif(9, 12), where the mixing probabilities η1 to η4
(
∑4
i=1 ηi = 1) are chosen to control the censoring rate at approximately 25%. For example, they
equal to (0.1, 0.1, 0.2, 0.6) for the simulation with informative biomarker and (0.1, 0.1, 0.1, 0.7) for
the simulation with non-informative biomarker. See the description of these two simulation scenar-
ios below.
The random intercept and random slope (time effect) are assumed to be positively correlated for
each biomarker. We allow Y i1 and Y i2 to have mild negative correlation, and Y i1 and Y i3 mild
positive correlation. The measurement times tij are irregularly spaced and unsynchronized among
different subjects. It was generated from tij = t˜j + eij , where {t˜j} is the scheduled measurement
times from 0 to 12 years with 0.5 increment and eij ∼ Unif(−0.17, 0.17). This setup corresponds
to the practical situation where the subject had clinical visit within a two-month window around
the scheduled visit times. For each simulation scenario, we used 500 Monte Carlo repetitions and
the sample size is n = 500.
2
Web Appendix B: Simulation on Local Linear Estimation
As explained in the Simulation section, the proposed landmark SDH model is a working model and
it is therefore difficult to simulate data so that the model holds at all landmark times. This is a
common feature of the landmark (or partly conditional) modeling approaches in general. In light
of this difficulty, we resort to a simple albeit approximate approach to evaluating the quality of the
proposed local linear estimation, at any landmark time s, as described below.
We simulated a cross-sectional time-to-event data set at a given landmark s, e.g., s = 3, which
was treated as baseline for the purpose of this simulation. Scattered individual measurement times
{tij} and the associated biomarker values Y i(tij) were simulated within a small neighborhood of
s. The proposed landmark SDH model was used to generate independent competing risks data
starting from each tij , following the simulation algorithm in Fine and Gray (1999). The log-SDH
β(s) is assumed to be a quadratic function of s (Web Figure 5). Note that this is not a really a
landmark dataset because each subject only has one tij . Nonetheless, this dataset exactly satisfies
the landmark SDH model so that we can use it to study the numerical performance of the proposed
local linear estimation in a small neighborhood of s. Specifically, we evaluate the bias of estimating
β(s) and the baseline CIF (Web Figure 6), pi0(t
∗; s) = 1 − exp
(
− ∫ t∗0 λ10(t, s)dt), as well as the
selection of the bandwidth.
The results are presented in Web Figure 7. The three columns from left to right are the plots
of the estimated log-SDH ratio, bias percentage, and mean squared error (MSE) against different
bandwidths. The rows from top to bottom correspond to the three increasing sample sizes. For
the plot of the log-SDH ratio (column 1), the mean estimated β(s) at s = 3 over the Monte Carlo
repetitions is close to the true value (red horizontal line) at small bandwidths (e.g. 0.3 and 0.5).
With increased bandwidth, the estimator shows increasing downward bias. This is because the
true β(s) function is concave (Web Figure 5), and the local linear fit underestimates it at the
peak as the bandwidth increases. The empirical standard errors, shown in Web Figure 7 as the
vertical whiskers, shrink with the increased bandwidth since more data points are included in the
kernel estimation. From top to bottom, the empirical standard errors decrease when the sample
size increases. Column 2 shows that the bias percentage generally increases with the bandwidth,
except when the bandwidth is very small, in which case larger finite-sample bias may result due
to very few data points available in the neighborhood defined by the bandwidth. In column 3, the
3
U-shaped MSE curve is a demonstration of the typical bias-variance trade-off in kernel estimation.
Overall, the percentage of absolute bias for the log-SDH ratio is very small, within 2% for middle
ranged bandwidths (the horizontal dashed line in column 2). The results from this simulation
suggests that the proposed local linear estimation works as expected from typical local polynomial
estimators.
Web Appendix C: Table and Figures
Web Table 1: The predicted CIF at different landmark times s and biomarker values m. The
true conditional risk (True) were obtained empirically using the method described in Section 5.
The average estimated CIF (EST), percent bias (%Bias), empirical standard deviation (ESD), and
mean-squared errors (×1, 000) (MSE) are reported. Prediction horizon τ1 = 3. The result is based
on 500 Monte Carlo repetitions.
True EST %Bias ESD MSE
m = 0 0.167 0.168 0.703 0.029 0.836
s = 1 m = 2 0.357 0.350 -2.030 0.025 0.670
m = 4 0.610 0.639 4.734 0.052 3.583
m = 0 0.278 0.295 6.262 0.052 3.001
s = 3 m = 2 0.516 0.503 -2.589 0.033 1.299
m = 4 0.729 0.755 3.463 0.053 3.419
m = 0 0.312 0.327 4.762 0.089 8.068
s = 5 m = 2 0.505 0.491 -2.795 0.062 4.104
m = 4 0.681 0.691 1.407 0.064 4.160
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Web Figure 1: Simulations with non-informative biomarker effect (upper panel) and informative
biomarker effect (lower panel). The point estimator of log-SDH ratios corresponding to the three
longitudinal biomarkers Y1, Y2 and Y3 (solid line) and their 95% empirical confidence limits
(dashed lines) are plotted over landmark time grids. The point estimator and the confidence limits
are defined as the average, 2.5% and 97.5% quantiles of the point estimators from the Monte Carlo
repetition.The horizontal dashed lines are the reference for zero effect. The estimated effects of the
three biomarkers are close to zero when the biomarkers are non-informative and deviate from zero
when the biomarkers are informative. Sample size n = 500.
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(a) ESRD
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(b) Death
Web Figure 2: The time-varying log-SDH ratios of Age, eGFR, eGFR.slope, log UP/Cr, Albumin
and history of hospitalization for the outcome of ESRD and death. Black solid curves are the time-
varying log-SDH ratios and grey dashed curves are the 95% confidence intervals from bootstrap.
Red dotted lines are the reference line of zero effect.
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(a) ESRD
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(b) Death
Web Figure 3: The time-varying log-SDH ratios of Age, eGFR, eGFR.slope, log UP/Cr and
Phosphorus for the outcome of ESRD; and the time-varying log-SDH ratios of Age, Albumin, log
Urine Potassium, and history of hospitalization for the outcome of Death. Black solid curves are
the time-varying log-SDH ratios and grey dashed curves are the 95% confidence intervals from
bootstrap. Red dotted lines are the reference lines of zero effect.
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Web Figure 4: The time-dependent ROC curves for predicting ESRD at landmark years 3, 5, and
7, with prediction horizon τ1 = 3 years. The areas under the ROC curves (AUCs) are annotated
on the plots.
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Web Figure 5: Simulation setting for Web Appendix B. For each subject, one longitudinal
biomarker value was simulated at a randomly picked time within a neighborhood (pink shaded
interval) of landmark time s = 3. The curve shows the shape of the coefficient function β(s).
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Web Figure 6: Estimation of baseline CIF in the simulation of Web Appendix B. The sample
sizes are 500, 1000 and 2000 respectively. True baseline CIF (red curve) and the average estimated
CIF over the Monte Carlo repetitions nearly overlap.
9
l l l l l l
1.
5
2.
0
2.
5
3.
0
n=500
Bandwidth
lo
g 
SD
H 
ra
tio
0.3 0.5 0.8 1.0 1.2 1.5
l
l
l
l
l
l
0
2
4
6
8
10
n=500
Bandwidth
bi
as
%
0.3 0.5 0.8 1.0 1.2 1.5
l
l
l l l
l
0.
00
0.
04
0.
08
n=500
Bandwidth
M
SE
0.3 0.5 0.8 1.0 1.2 1.5
l l l l l l
1.
5
2.
0
2.
5
3.
0
n=1000
Bandwidth
lo
g 
SD
H 
ra
tio
0.3 0.5 0.8 1.0 1.2 1.5
l
l
l
l
l
l
0
2
4
6
8
10
n=1000
Bandwidth
bi
as
%
0.3 0.5 0.8 1.0 1.2 1.5
l
l
l l
l
l
0.
00
0.
04
0.
08
n=1000
Bandwidth
M
SE
0.3 0.5 0.8 1.0 1.2 1.5
l l l l l l
1.
5
2.
0
2.
5
3.
0
n=2000
Bandwidth
lo
g 
SD
H 
ra
tio
0.3 0.5 0.8 1.0 1.2 1.5
l
l
l
l
l
l
0
2
4
6
8
10
n=2000
Bandwidth
bi
as
%
0.3 0.5 0.8 1.0 1.2 1.5
l
l l l
l
l
0.
00
0.
04
0.
08
n=2000
Bandwidth
M
SE
0.3 0.5 0.8 1.0 1.2 1.5
Web Figure 7: Simulation results for the finite sample performance of local linear estimation (Web
Appendix B). The average estimated log-SDH ratio, absolute bias percentage and mean squared
error (MSE) are plotted against the bandwidth on the horizontal axis. The sample size equals
to 500, 1000, and 2000. The bias-variance trade-off and their relationship with the bandwidth
resemble the typical behavior of local polynomial estimation.
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